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llogeneic mixed leucocyte reaction
a  b  s  t  r  a  c  t
Dendritic  cells  (DCs)  are  critical  for  the  generation  of  T-cell  responses.  DC function  may  be  modulated
by probiotics,  which  confer  health  beneﬁts  in  immunocompromised  individuals,  such  as  the elderly.
This  study  investigated  the  effects  of  four  probiotics,  Biﬁdobacterium  longum  bv.  infantis  CCUG  52486,
B. longum  SP 07/3,  Lactobacillus  rhamnosus  GG  (L.GG)  and  L. casei  Shirota  (LcS),  on DC  function  in an
allogeneic  mixed  leucocyte  reaction  (MLR)  model,  using  DCs  and  T-cells  from  young and  older  donors
in different  combinations.  All  four  probiotics  enhanced  expression  of CD40,  CD80  and  CCR7  on  both
young  and  older  DCs,  but enhanced  cytokine  production  (TGF-,  TNF-)  by  old  DCs  only.  LcS  induced
IL-12  and  IFN  production  by  DC to  a greater  degree  than  other  strains,  while  B.  longum  bv.  infantisytokine
endritic cells
robiotics
CCUG  52486  favoured  IL-10  production.  Stimulation  of  young  T cells  in an  allogeneic  MLR  with  DC  was
enhanced  by  probiotic  pretreatment  of  old  DCs,  which  demonstrated  greater  activation  (CD25)  than
untreated  controls.  However,  pretreatment  of  young  or  old  DCs  with  LPS  or  probiotics  failed  to enhance
the proliferation  of  T-cells  derived  from  older  donors.  In  conclusion,  this  study  demonstrates  that  ageing
increases  the  responsiveness  of  DCs  to probiotics,  but  this  is  not  sufﬁcient  to  overcome  the  impact  of
e  MLRimmunosenescence  in th
ntroduction
Evidence suggests that probiotic bacteria modulate both innate
nd adaptive immunity in the host and may  have therapeutic appli-
ations for various diseases (Jonkers et al., 2012; Yesilova et al.,
012). Probiotics modulate dendritic cell (DC) function (Baba et al.,
008; Ng et al., 2009), but the effects of individual strains are not
lear and the underlying mechanisms are not well deﬁned. VSL#3,
 probiotic combination of several Biﬁdobacterium and Lactobacil-
us strains, confers immunoregulatory effects via induction of IL-10
y bone-marrow derived DCs in mice (Drakes et al., 2004), by
uman blood DCs in vitro (Hart et al., 2004) and by intestinal DCs
oth in vivo and in vitro (Ng et al., 2010). However, some stud-
es have demonstrated pro-inﬂammatory effects of Lactobacillus
Mohamadzadeh et al., 2005) and B. breve (Latvala et al., 2008), as
videnced by induction of IL-12 and/or IFN- by human myeloid or
onocyte-derived DCs.
DCs have pivotal roles in shaping adaptive immune responses,
ut there are conﬂicting data regarding DC-T cell interactions in
esponse to probiotics. Several strains of Lactobacillus have been
Abbreviations: DCs, dendritic cells; LcS, L. casei Shirota; MLR, mixed leucocyte
eaction; PRPs, pathogen recognition patterns; PAMPs, pathogen-associated molec-
lar  patterns; CFSE, carboxyﬂuorescein diacetate succinimidyl ester.
∗ Corresponding author. Tel.: +44 118 378 8720; fax: +44 118 378 7708.
E-mail address: p.yaqoob@reading.ac.uk (P. Yaqoob).
171-2985/$ – see front matter ©  2013 Elsevier GmbH. All rights reserved.
ttp://dx.doi.org/10.1016/j.imbio.2013.08.012.
© 2013 Elsevier GmbH. All rights reserved.
demonstrated to “educate” human monocyte-derived DCs to elicit T
regulatory responses by increased production of IL-10 (Smits et al.,
2005), and also to stimulate CD4+ T helper cell responses (Braat
et al., 2004). However, the probiotic VSL#3 did not enhance the
ability of bone-marrow derived DCs to stimulate proliferation of T
cells in mice (Drakes et al., 2004), or the ability of blood-enriched
or intestinal tissue-derived DCs to induce IL-10 production by T
cells (Hart et al., 2004). An understanding of the factors inﬂuencing
interactions between probiotic bacteria and DCs is critical in deter-
mining how they are distinguished from pathogens and how they
modulate immune responses.
In the gut, DCs sample bacteria by passing dendrites through
the tight junctions between epithelial cells into the gut lumen
(Rescigno et al., 2001) or indirectly interact with bacteria that
have gained access to M cells (Stagg et al., 2003). Gut  DCs can
be directly regulated by ingested probiotics by pathogen recogni-
tion patterns (PRPs) expressed on their surface, which recognise
pathogen-associated molecular patterns (PAMPs) on bacteria.
This recognition process induces DC maturation, characterised
by up-regulation of co-stimulatory molecule expression, cytokine
secretion and by DC- induced activation of T cells (Langenkamp
et al., 2000; Mellman and Steinman 2001). DC-derived signals
determine the nature of T cells responses, i.e. polarization of T
helper cells to Th1, Th2, Th17 or T regulatory response (Kapsenberg
2003).
Some studies suggest that the ability of probiotics to modulate
the cytokine proﬁle of DCs is to some extent inﬂuenced by the
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peciﬁc genera, species or strain (Christensen et al., 2002; Hart et al.,
004; Young et al., 2004; O’Mahony et al., 2006; Zeuthen et al.,
006; Baba et al., 2008; Latvala et al., 2008; Zeuthen et al., 2008).
iﬁdobacteria are, in general, better inducers of IL-10, but poor
nducers of IL-12, whereas lactobacilli tend to induce strong pro-
nﬂammatory responses and are weaker inducers of IL-10 (Dong
t al., 2010; Shida et al., 2011; Dong et al., 2012). However, the
ata is not always consistent and the wider impact of strain-speciﬁc
nduction of cytokine production on immune responses is not clear.
hus, there is a need for direct comparison of the immunomod-
latory effects of probiotic strains, especially with regard to DC
unction.
Ageing is a key factor determining immune responsiveness to
athogens (Lazuardi et al., 2005; Weng 2006; Uciechowski et al.,
008; Panda et al., 2009). Ageing also alters the gut microenviron-
ent and there is considerable interest in the potential beneﬁts of
robiotic administration in older individuals (Hopkins et al., 2001).
here is evidence that ageing results in DCs with weakened ability
o modulate T cell responses (Grolleau-Julius et al., 2008; Agrawal
nd Gupta 2011); thus we hypothesise that there may be particu-
ar beneﬁt of probiotics in restoring DC function. However, there is
ittle or no information comparing the effects of probiotics on DCs
rom young vs older subjects.
The aim of the current study was to compare the effects of four
robiotics, a novel probiotic strain (B. infantis CCUG 52486) and
hree commercial probiotic bacteria (B. longum SP 07/3, L. GG and
cS), on DC phenotype and the ability to generate speciﬁc T-cell
esponses, and also to examine whether the immunomodulatory
ffects of probiotics were inﬂuenced by ageing.
aterials and methods
robiotic strain preparation
Stock strains (B. infantis 52486, B. longum SP 07/3, L.GG, and LcS)
ere stored frozen at −80 ◦C in Microbank® mixed vials accord-
ng to the manufacturer’s instructions (ProLab Diagnostics). After
efrosting, the strains were grown in MRS  agar plates (Oxoid Ltd.,
K) at 37 ◦C under anaerobic conditions for 3 days. A single colony
rom each strain was then transferred to a hungate tube con-
aining 10 ml  MRS  broth (Oxoid Ltd., UK) with 0.05% l-cysteine
ydrochloride (Sigma) and incubated for a further 24 h under the
ame conditions. Following this, 100 l of the liquid culture was
emoved, added to a new MSR  broth tube and grown at 37 ◦C in a
haking incubator (Cooled Orbital Incubator, Gallenkamp, Lough-
orough, UK). Bacteria were harvested in the exponential phase and
ransferred to centrifuge tubes. After washing twice at 400 × g for
0 min, the bacteria were resuspended in 1 ml  RPMI 1640 medium
Lonza, UK) and diluted to a concentration of 1 × 107 cfu/ml.
eripheral blood mononuclear cell (PBMC) preparation and
ulture
Peripheral blood was obtained from healthy young (20–30
ears) and old (65–75 years) subjects. Exclusion criteria included
iabetes requiring medication, asplenia and other acquired or con-
enital immunodeﬁciencies, any autoimmune disease, malignancy,
irrhosis, connective tissue diseases; current use of immunomodu-
ating medication (including oral prednisone and inhaled steroids),
elf-reported symptoms of acute or recent infection (including use
f antibiotics within last 3 months), alcoholism and drug misuse
University of Reading Ethics Committee project ref 10/05). Blood
as diluted into an equal volume of RPMI 1640 medium. PBMCs
ere isolated by density gradient centrifugation over Ficoll-Paque
Fisher Scientiﬁc, UK), and resuspended in RPMI 1640 medium 219 (2014) 138– 148 139
with 10% foetal calf serum (Sigma Ltd., UK). PBMCs were cultured
overnight in culture ﬂasks (4 × 106 cells/ml) in a 37 ◦C, 5% CO2
atmosphere.
Human blood DC enrichment and culture
Low Density Cells (LDCs) were prepared as the source of
human blood-enriched dendritic cells, which had morphological
characteristics of DCs, as described in previous studies (Knight
et al., 1986; Kerdiles et al., 2010). This LDC population was
used as a source of human blood DC because cells are usually
98–100% HLA-DR positive and stimulate strong proliferation of
allogeneic T-cells at very low concentrations (Knight et al., 1986;
Holden et al., 2008). Allostimulatory activity of the LDC popula-
tion is attributable only to DCs because they are the only cells
present capable of stimulating primary T cell responses in the MLR
(McLellan et al., 1995a,b). After overnight culture of PBMC, the
non-adherent cells were collected and centrifuged over Nycoprep
(500 × g, 15 min) (PROGEN Biotechnik GmbH). LDCs were removed
from the interface, washed twice (650 × g, 5 min) in RPMI 1640
medium with 10% foetal calf serum and re-suspended in the same
medium.
Harvested LDCs were adjusted to a concentration of 1 × 106
cells/ml and cultured with 10 g/ml LPS, with 0.5 × 106 cfu/ml of
probiotic bacteria or without stimuli in a 37 ◦C, 5% CO2 atmosphere
for 24 h.
T cell puriﬁcation and DC stimulation of T cells
In this allogeneic mixed leucocyte reaction (MLR), T cells were
obtained from blood donated by healthy young or older subjects,
which were different from the DC donors. After isolating PBMCs
as described above, T cells were separated by negative isolation
using a Human T cell enrichment kit (BD Bioscience, UK). Prior to
culture, puriﬁed T cells were labelled with carboxyﬂuorescein diac-
etate succinimidyl ester (CFSE, Invitrogen Ltd., UK) for subsequent
assessment of T cell proliferation (Lyons and Parish 1994; Bernardo
et al., 2012). T cells (4 × 105) from young and older subjects were
co-incubated with 0% or 3% cultured LDCs from young and older
subjects in a 37 ◦C, 5% CO2 atmosphere for 5 days.
Intracellular cytokine production
Intracellular cytokine production by DCs following 24 h incu-
bation in the presence or absence of LPS, or by T cells following
the MLR  was  analysed using ﬂow cytometry. Cells were incu-
bated with or without 50 l Monensin (3 M)  (eBioscience Ltd.,
UK) in a 37 ◦C, 5% CO2 atmosphere for 4 h, washed in FACS
buffer (BD Bioscience, UK) and stained with the appropriate
surface marker antibodies. They were then ﬁxed, permeabilised
and ﬁnally stained with appropriate antibodies for intracellular
cytokines.
Antibody staining
For identiﬁcation and characterisation of peripheral blood DCs,
LDCs were stained with a lineage cocktail containing antiCD3, CD14,
CD19, CD20 (FITC) and HLA-DR (APC, PerCP-Cy 5.5 or PE). This
was  used in conjunction with antibodies for maturation markers
(CD80 (PE-Cy 7), CD86 (APC) and CD40 (APC-Cy 7)) and a migra-
tion marker, C C chemokine receptor type7 (CCR7) (PerCP-Cy 5.5).
Peripheral blood DCs were identiﬁed as positive for HLA-DR and
negative for the lineage cocktail. T cells were identiﬁed by CD3
(PE-Cy 7, APC or APC-Cy 7) staining and classiﬁed into CD4 (PE-
Cy 7) and CD8 (PerCP-Cy 5.5) subsets. CD25 (APC) was used as
a marker for T cell activation; and integrin 7 (PE) was used as
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Fig. 1. Effects of probiotics on surface marker expression by DCs.
Data are mean ± SE for n = 8 samples from each group. Data were normalised by the Johnson Transformation. There was  a signiﬁcant effect of age (P < 0.05) on expression of
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he  same age group (post hoc tests with Bonferroni correction).
 homing marker for T cells. Antibodies against IL-10 (PE), IL-12
PE), TNF- (PerCP-Cy 5.5), IFN- (APC-Cy 7) and TGF- (PE-Cy 7)
ere used to assess intracellular cytokine production by DCs or DC-
timulated T cells. Isotype-matched control antibodies included rat
gG2a (PE), mouse IgG1 (FITC, PE, PE-Cy 7, PerCP-Cy 5.5, APC-Cy
), mouse IgG2a (PerCP-Cy 5.5) and mouse IgG2b (PerCP-Cy 5.5).
tained cells were incubated at room temperature in the dark for
0–45 min, washed twice, resuspended in 500 l of Fix solution
nd kept at 4 ◦C until analysis by ﬂow cytometry. The lineage cock-
ail, CD80, HLA-DR (APC), CD3 (APC-Cy 7), CD25, CD69, IL-10, IL-12
nd rat IgG2a were purchased from BD Biosciences, UK, and all
ther antibodies were purchased from Cambridge Bioscience Ltd.,
K.
low cytometric analysis
Samples were analysed using a FACSCanto II ﬂow cytometer (BD,
K). Data were analysed by superenhanced Dmax (SED) normalised
ubtraction using FlowJo software.
tatistical analysis
Statistical analysis was  performed using Mini Tab 16.0. Data
ere tested for normality and transformed using the Johnson
ransformation where appropriate. Signiﬁcant differences were
valuated by the Student’s t-test or two-way ANOVA using the
eneral Linear Model, followed by appropriate post hoc tests
ith Bonferroni correction. All data are shown as mean ± SE
standard error). The statistical signiﬁcance level was set at
 < 0.05.ay ANOVA). Signiﬁcant differences are denoted as P < 0.05 relative to control for
Results
Probiotics induce DC maturation and may affect homing ability
There was  a signiﬁcant effect of treatment (LPS or probiotics) on
expression of CD40 (P < 0.01), CD80 (P < 0.001) and CCR7 (P < 0.01),
but not CD86. All probiotic strains enhanced DC expression of CD40
and CD80, and the lymph-node homing marker, CCR7, although
this was  not statistically signiﬁcant in the case of CD40 in young
DC treated with LcS, and CD80 and CCR7 in young DC treated with
L. GG (Fig. 1). There was also a signiﬁcant inﬂuence of age on the
expression of CD80 in response to L. GG,  whereby L. GG increased
CD80 expression by DCs from older subjects, but not young subjects
(Fig. 1). There was  no inﬂuence of ageing on the DC response to the
other probiotics.
Induction of DC cytokine production by probiotics is
age-dependent
There was  a signiﬁcant effect of treatment (P < 0.05) on expres-
sion of all cytokines, and expression of TGF- (P < 0.01), TNF-
(P < 0.05) and IFN- (P < 0.05) in response to probiotics was  sig-
niﬁcantly inﬂuenced by age (two-way ANOVA). All four of the
probiotics increased the proportion of TGF- producing cells in
older subjects, but not younger subjects compared with unstim-
ulated DCs, while LPS induced TGF- production to similar levels
in young and old DCs (Fig. 2). Thus, probiotics induced TGF- pro-
duction more effectively in older DCs (Fig. 2). Induction of TNF-
by LPS was  signiﬁcantly greater in young DC compared to old DC,
but probiotics did not induce TNF- production by either young or
J. You et al. / Immunobiology 219 (2014) 138– 148 141
Fig. 2. Effects of probiotics on intracellular cytokine production by DCs.
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DCs with probiotics increased expression of CD25 by young T cells
to a level comparable to or greater than with LPS (Fig. 4). Older
DCs were therefore signiﬁcantly more responsive to all four pro-
biotic strains than young DC in terms of inducing activation of
Fig. 3. Effects of probiotics on IL-10/IL-12 ratio in DCs.
Data are mean ± SE for n = 8 samples from each group. Data were normalised by theata are mean ± SE for n = 8 samples from each group. Data were normalised by the
GF-,  TNF- and IFN- and of treatment (P < 0.05) on expression of all cytokines (tw
ame  age group; L P < 0.05 relative to B. longum SP 07/3 for the same age group; G P 
ld DC compared with the unstimulated controls (Fig. 2). Never-
heless, the proportion of TNF- producing DCs was  signiﬁcantly
igher in the old DCs compared with the young DCs when treated
ith probiotics (Fig. 2). There was no inﬂuence of ageing on IL-12
nduction, and only two  of the probiotics (B. longum SP 07/3 and
cS) induced IL-12 (Fig. 2). In contrast, all four probiotics induced
L-10 production by old DCs, but only B. longum infantis CCUG 52486
nduced it in young DCs (Fig. 2); as with the effects on TGF-, this
uggests that probiotics induced IL-10 production more effectively
n older subjects, although statistically, there were no signiﬁcant
ifferences between the young and old DCs under each treatment
ondition. DCs from older subjects had signiﬁcantly higher basal
xpression of IFN- than those from young subjects (Fig. 2). LPS
ncreased IFN- production by young DCs only, and LcS induced
FN- production by older DCs only (Fig. 2). Overall, LPS strongly
nduced DC cytokine production in both young and older subjects
although to a greater degree in young subjects), but the probiotics
ended to induce greater responses in the older subjects; this was
ost apparent for TGF- and TNF- (Fig. 2). There were relatively
ew strain differences – these chieﬂy related to greater induction
f IL-12 and IFN- by LcS compared with L. GG (Fig. 2).
Fig. 3 shows the IL-10/IL-12 ratio following exposure to LPS or
robiotics. There was a signiﬁcant effect of treatment (P < 0.05) but
o signiﬁcant effect of age on the IL-10/IL12 ratio. IL-10/IL-12 ratio
as signiﬁcantly increased by LPS, B. longum infantis CCUG 52486
nd LcS in both young and older subjects, and by B. longum SP 07/3
nd L.GG only in older subjects (Fig. 3). B. longum infantis CCUG
2486 had the greatest regulatory effect compared with the other
trains (Fig. 3).
robiotics affect DC-induced activation of T cells in an
ge-dependent mannerT cells from older subjects did not respond to DCs in the MLR,
egardless of LPS/probiotic-stimulation and age of DCs (Fig. 4). In
ontrast, young T cells did respond to unstimulated DCs by upre-
ulating expression of CD25, regardless of the age of the DC donorson Transformation. There was a signiﬁcant effect of age (P < 0.05) on expression of
y ANOVA). Signiﬁcant differences are denoted as C P < 0.05 relative to control for the
 relative to L.GG for the same age group (post hoc tests with Bonferroni correction).
(Fig. 4). Activation of young CD4+ T cells was further increased by
pre-treatment of young and old DCs with LPS (Fig. 4). However, LPS
stimulation of older DCs failed to upregulate expression of CD25 by
CD8+ young T cells, suggesting some age-related impairment of the
priming capability of DCs (Fig. 4).
When young T cells were used in the MLR, probiotics enhanced
the priming capability of older DCs, but not young DCs (Fig. 4),
as illustrated by the fact that pre-treatment of young DCs with
probiotics had no effect on expression of CD25 by either CD4+ or
CD8+ young T cells (Fig. 4). In contrast, pre-incubation of olderJohnson Transformation. There was  a signiﬁcant effect of treatment (P < 0.05) on the
IL-10/IL-12 ratio (two-way ANOVA). Signiﬁcant differences are denoted as C P < 0.05
relative to control for the same age group; L P < 0.05 relative to B. longum SP 07/3 for
the same age group; G P < 0.05 relative to L.GG for the same age group (post hoc tests
with Bonferroni correction).
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Fig. 4. Effects of probiotics on DC-induced CD25 expression by T cells.
T  cells and subsets in the MLR culture were distinguished by staining with anti-CD3, CC4 and CD8. Data are mean ± SE for n = 8 samples from each group. Data were normalised
by  the Johnson Transformation. There was a signiﬁcant effect of ageing (P < 0.01) on CD25 expression and of treatment (P < 0.05) on CD25 expression by both CD4+ and CD8+
young T cells (two-way ANOVA). Signiﬁcant differences are denoted as N P < 0.05 relative to the no-DC controls for T cells within the same age group; D P < 0.05 relative to
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ells  (post hoc tests with Bonferroni correction).
D4+ T cells from young subjects, whereas only B. longum infan-
is CCUG 52486 and LcS enhanced the ability of older DCs to
nduce activation of CD8+ T cells from young subjects (Fig. 4).
he effects of ageing on the CD8+ T cell population were par-
icularly marked (Fig. 4), in line with a more marked reduction
n the proportion of naïve cells within this subset (data not
hown).
robiotics enhance DC-induced expression of integrin ˇ7 by
oung, but not older T cells
Unstimulated DC did not affect expression of gut-homing
arker integrin 7 by T cells (Fig. 5). Pre-incubation of DCs (young
nd old) with either LPS or probiotics upregulated integrin 7
xpression on young T cells, but not older T cells (Fig. 5). An
xception to this was that B. longum infantis CCUG 52486 did not
nhance DC-induced integrin 7 expression above that observed
ith unstimulated DC (Fig. 5). For older T cells, DC failed to increase
ntegrin 7 expression, regardless of the nature of stimulation, or
he age of the donor DC (Fig. 5).ive to L.GG for the same age group of DCs within the same age group of T cells; T
s are donated as * P < 0.01 for the same treatment within the same age group of T
Probiotics increase the ability of DCs to induce cytokine
production by young T cells
When young T cells were used in the MLR, TGF- production
by the young T cells was  increased to an equal degree by unstimu-
lated and LPS-stimulated DCs, regardless of the age of the donor DCs
(Fig. 6). All four probiotic strains also upregulated TGF- production
by young T cells, but the effect was signiﬁcantly greater when old
DC were used in the MLR, suggesting that older DC are more respon-
sive to probiotics and this induces greater cytokine production by
young T cells (Fig. 6). Unstimulated DCs also induced production
of IL-10 by young T cells (Fig. 7). All four probiotics enhanced DC-
induced production of IL-10 by young T cells, but the effects of B.
longum infantis CCUG 52486 were signiﬁcantly greater than those
of the other three strains, and there was  no inﬂuence of the age of
the donor DC (Fig. 6).
The effects of pre-treatment of DCs with probiotics on produc-
tion of IL-12 and TNF- by young T cells were more variable, and
there was no effect of probiotics on production of IFN- by young
T cells (Figs. 6 and 7). There was  no inﬂuence of DC donor age on
induction of these cytokines by young T cells (Fig. 7).
J. You et al. / Immunobiology 219 (2014) 138– 148 143
Fig. 5. Effects of probiotics on DC-induced expression of integrin 7 by T cells.
T  cells in the MLR  culture were identiﬁed by staining with anti-CD3. Data are mean ± SE for n = 8 samples from each group. Data were normalised by the Johnson Transformation.
There  was a signiﬁcant effect of age (P < 0.05) and of treatment (P < 0.05) on expression of integrin 7 (two-way ANOVA). Signiﬁcant differences are denoted as N P < 0.05
r D e to D T
r re don
h
w
w
n
p
e
r
P
a
e
L
b
D
w
p
e
e
p
D
r
o
i
i
p
n
b
e
a
t
2
w
e
nelative  to the no-DC control for T cells within the same age group; P < 0.05 relativ
elative to older T cell with the same treatment. Signiﬁcant age-differences of DCs a
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When old T cells were used in the MLR, only IL-10 and TNF-
ere induced by unstimulated DCs (P < 0.05), and pre-treatment
ith LPS/probiotics did not further enhance this (Fig. 7). There was
o inﬂuence of age of the DC donor and no differences between
robiotic strains. Overall, these data demonstrate that probiotics
nhance the priming capability of old DCs, and this subsequently
esults in enhanced priming of young T cells, but not old T cells.
robiotics inﬂuence DC-induced proliferation of T cells in an
ge-dependent manner
Young T cells stimulated by young DCs demonstrated the great-
st rate of proliferation (Fig. 8). Pre-incubation of young DC with
PS or probiotics further enhanced the proliferation of young T cells,
ut pre-treatment of older DC had no effect, suggesting that young
C were responsive to priming by probiotics (when proliferation
as the outcome), while older DC were not (Fig. 8). In contrast,
re-incubation of either young or old DC with probiotics failed to
nhance DC-induced proliferation of old T cells, demonstrating that
ven though young DC were responsive to probiotics, they failed to
rime older T cells (Fig. 8).
iscussion
This study demonstrates that ageing is associated with increased
esponsiveness of DCs to probiotics, but this is not sufﬁcient to
vercome the impact of immunosenescence in the MLR, which
ncludes a shift in the proportion of naïve to memory cells. Age-
ng alters the gut microenvironment and results in a gradual and
rogressive decline in immune function, described as immunose-
escence, and it has therefore been suggested that there might
e particular beneﬁts of probiotics in older individuals (Hopkins
t al., 2001). DCs are at a crossroad between the innate and
daptive immune systems, and are targets for immunomodula-
ion by probiotics (Meijerink and Wells 2010; Feyisetan et al.,
012). It has been suggested that ageing results in DCs with
eakened ability to modulate T cell responses (Grolleau-Julius
t al., 2008; Agrawal and Gupta 2011), but to our knowledge,
o studies have directly compared the responses of DCs fromC-stimulated T cells (without LPS/probiotics) within the same age group; P < 0.05
ated as * P < 0.01 for the same treatment within the same age group of T cells (post
young and older subjects to probiotics using human blood-derived
DCs.
In the current study, expression of CD40, CD80, and the lymph
node homing marker, CCR7, on DCs from young and older sub-
jects was enhanced by all four probiotics tested. This supports
previous studies using murine monocyte-derived DCs (Christensen
et al., 2002; Drakes et al., 2004), human monocyte-derived DCs
from peripheral blood (Braat et al., 2004; Zeuthen et al., 2006;
Baba et al., 2008; Latvala et al., 2008; Elmadfa et al., 2010; Evrard
et al., 2011) or cord blood (Young et al., 2004), and myeloid DCs
(Mohamadzadeh et al., 2005). There was little inﬂuence of ageing
on the ability of probiotics to promote maturation of DCs, except
that L.GG had a signiﬁcantly greater effect on CD80 expression by
DCs from older subjects than those from young subjects. Expres-
sion of CD86 by unstimulated DCs was  high (>80%), consistent
with published data (McLellan et al., 1995a,b; Langenkamp et al.,
2000), and was  not inﬂuenced by treatment with LPS or probio-
tics.
Production of TGF- and TNF- by DCs from older subjects in
response to all four probiotics was  signiﬁcantly greater than that
by DCs from young subjects, which did not respond to probiotics. In
addition, LcS was particularly effective in increasing IFN- produc-
tion by older DCs. Reported effects of ageing on cytokine production
by DCs in response to stimuli are not consistent; some studies
report decreased production of IL-6, IL-10, IL-12, TNF- and/or IFN-
 by circulating DCs, bone marrow-derived DCs  and splenic DCs in
elderly subjects (Grolleau-Julius et al., 2006; Della Bella et al., 2007;
El Mezayen et al., 2009; Panda et al., 2010; Wong et al., 2010),
while others report unimpaired or increased production by LPS-
stimulated monocyte-derived DCs from older people (Lung et al.,
2000; Agrawal et al., 2007). This may  be partly due to the differ-
ent types of DCs used. The impact of greater production of TGF-
and TNF- by DCs in response to probiotics during ageing is not
clear; greater induction of TNF- may be useful in initiating a pro-
inﬂammatory response during infection, but dysregulation may
be associated with autoimmunity and hyperinﬂammation (O’Shea
et al., 2002; van Horssen et al., 2006; Ko et al., 2011). Enhancement
of TGF- production by probiotics may  modulate inﬂammation
(Commodaro et al., 2010), and promote the generation of DCs from
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Fig. 6. Effects of probiotics on DC-induced intracellular cytokine production (TGF-, TNF- and IFN-) by T cells.
T  cells in the MLR  culture were identiﬁed by staining with anti-CD3. Data are mean ± SE for n = 8 samples from each group. Data were normalised by the Johnson Transformation.
There was  a signiﬁcant effect of age (P < 0.05) on expression of TGF- and IFN- on young T cells and of treatment (P < 0.05) on TGF- on young T cells and TNF- on young
and  old T cells (two-way ANOVA). Signiﬁcant differences are denoted as N P < 0.05 relative to the no-DC control for T cells within the same age group; D P < 0.05 relative to
D relativ
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sC-stimulated T cells (without LPS/probiotics) within the same age group; T P < 0.01 
f  DCs are donated as * P < 0.01 for the same treatment within the same age group o
onocytic/macrophagic cells (Fortunel et al., 2000). Thus, the rela-
ive inﬂuence of probiotics on resistance to infection and regulation
f inﬂammation is not clear.
It  is important to note that cytokine production by LPS-
timulated DCs was relatively unaffected by ageing (with the
xception of lower levels of TNF- in older DCs). The fact that there
as age-related enhancement of responsiveness of DCs to probio-
ics, but not LPS, suggests that the TLR4 pathway may  be unaffected
y ageing (as suggested by human and animal studies (Agrawal
t al., 2007; Comin et al., 2007)); however, it has yet to be deter-
ined whether pathways activated by gram positive bacteria are
ubject to modulation by ageing.e to T cells from older subjects with the same treatment. Signiﬁcant age-differences
lls (post hoc tests with Bonferroni correction).
Overall, the current study suggests that DCs from older subjects
were more responsive to probiotics. It was  therefore hypothesised
that DCs from older subjects pre-treated with probiotics would be
more effective in the MLR  than DCs from young subjects. This was
indeed the case for expression of CD25 and TGF-, and to some
extent, integrin 7, by T cells from young subjects exposed to
probiotic-treated DCs in the MLR. This supports the idea that ageing
enhances the responsiveness of DCs to modulation by probiotics.
Interaction of integrin 7 with its ligands has been implicated
in promoting immune homeostasis, in protecting against mucosal
pathogens but also in the pathogenesis and development of gut
inﬂammation e.g. inﬂammatory bowel disease (IBD) (Gorfu et al.,
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Fig. 7. Effects of probiotics on DC-induced intracellular production of IL-12 and IL-10 by T cells.
T  cells in the MLR  culture were identiﬁed by staining with anti-CD3. Data are mean ± SE for n = 8 samples from each group. Data were normalised by the Johnson Transformation.
There  was  a signiﬁcant effect of age (P < 0.05) on expression of IL-12 and IL-10, and treatment (P < 0.05) on IL-12 on young T cells and IL-10 on young and older T cells (two-way
ANOVA). Signiﬁcant differences are denoted as N P < 0.05 relative to the no-DC control for T cells within the same age group; D P < 0.05 relative to DC-stimulated T cells (without
LPS/probiotics) within the same age group; T P < 0.01 relative to T cells from older subjects with the same treatment; I P < 0.01relative to B. infantis 52486 for the same age
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aroup  of DCs within the same age group of T cells; B P < 0.05 relative to B. infantis 52
ests  with Bonferroni correction).
009). It is worth noting that the novel strain, B. infantis CCUG
2486, increased the ability of old DCs to induce the expression of
his gut homing marker on young T cells in preference to young DCs.
he effect of ageing on integrins is not clear, with studies reporting
ither increased (Peres et al., 2003), decreased (Crooks et al., 2010)
r unaffected expression (De Martinis et al., 2000). The implications
f a potential enhancement of integrin 7 expression by probiotics
s also unclear; it could be speculated that it may  be helpful for pro-
oting the recruitment of responding T cells to infected sites in the
ut and decelerating the loss of homeostatic control during ageing
f DCs.
It is worth noting that, DCs from older subjects are able to induce
ctivation (CD25) of young T cells, but yet they fail to proliferate
ffectively. The reasons for this are not clear, but could be partly
ue to the potential inhibitory effect of CD4+ CD25+ T cells on T cell
roliferation (Ge et al., 2002). Decreased proliferation of T cells is a
ommon feature of ageing and involves both a lower percentage of
roliferating cells and fewer rounds of division (Jiang et al., 2007).
mportantly, it has been demonstrated that cytokine production
y PBMC or T cell subsets from aged donors is unimpaired, or even
ncreased, and yet proliferation in response to a mitogen is severely
mpaired, suggesting different signalling pathways may  regulate
he age-associated change on T cell activation/cytokine production
nd proliferation in response to antigen (Tortorella et al., 2002). Ind L.GG for the same age group of DCs within the same age group of T cells (post hoc
the current study, IL-12 production in the MLR with older T cells
was  extremely low, and signiﬁcantly lower than that in the MLRs
with young T cells. Since IL-12 is critical for efﬁcient T helper cell
proliferation and also important for cytotoxic T cells (Gately et al.,
1991; Valenzuela et al., 2002; Yoo et al., 2002), it could be spec-
ulated that this may  play a role in the irresponsiveness of older
T cell proliferation. In fact, when T cells from older subjects were
used in the MLR, the inﬂuence of both the probiotics and the age
of the donor DC were all lost in the current study, suggesting that
ageing substantially impairs the T cell response to DCs and that the
increased responsiveness of ageing DCs to probiotics might be a
compensatory mechanism for the decline in T cell function.
Impaired activation of signalling pathways, such as the
serine/threonine-speciﬁc protein kinase pathways and the
MEK/ERK pathway, have been demonstrated to account for
decreased T cell activation associated with ageing (Miller 2000).
Among them, dysregulation of signals that recruit PKC to T cells
particularly deﬁnes the impaired T cell response to DCs in older
people (Monks et al., 1997). However, the inﬂuence of ageing on
TLR function and expression is not clear, and data on age-related
changes on TLR expression is not consistent (Agrawal and Gupta
2011). The inﬂuence of age of the donor on the response of DCs
and T cells in the MLR  to probiotics has considerable implications
for in vitro work investigating the effects of probiotics on immune
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Fig. 8. Effects of probiotics on proliferation of T cells in the MLR.
T  cells in the MLR  culture were identiﬁed by staining with anti-CD3. Data are presented as % of T cells diving induced by un-stimulated or LPS/probiotics-stimulated DCs. Data
are  mean ± SE for n = 8 samples from each group. Data were normalised by the Johnson Transformation. There was a signiﬁcant effect of age (P < 0.01) on T cell proliferation
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ynd  of treatment (P < 0.01) on young T cell proliferation (two-way ANOVA). Signiﬁc
ge  group; D P < 0.05 relative to DC incubated T cell (without LPS/probiotics) with 
ests  with Bonferroni correction).
unction, where the age of the donor may  not be taken into account,
nd potentially also for human intervention studies.
In the current study, for the most part, all four probiotic strains
odulated DC and T cell function in a similar manner. The main
train-speciﬁc differences were that LcS treatment of DCs was
articularly potent at inducing IL-12 production by young T cells
nd pretreatment of DCs with B. infantis CCUG 52486 induced
igh levels of IL-10 by young T cells. This is consistent with the
ell-documented observation that lactobacilli tend to induce pro-
nﬂammatory cytokine proﬁles, whereas biﬁdobacteria tend to
nduce IL-10 due to their high content of CpG motifs (Yi et al., 2002;
edina et al., 2007; Dong et al., 2010; Shida et al., 2011; Dong
t al., 2012). Exposure of DCs to B. longum infantis CCUG 52486
esulted in the highest IL-10/IL-12 ratio. B. infantis CCUG 52486 is
 novel strain, which has shown promising in vitro antimicrobial
ctivity as a growth inhibitor of the pathogen, Clostridium difﬁcile,
he main etiologic agent of pseudomembranous colitis and one of
he major reasons for antibiotic-associated diarrhoea (Gougoulias,
007), but to date, there is only one study demonstrating that it has
mmunomodulatory potential (You and Yaqoob 2012). The current
tudy supports this and furthermore suggests that B. infantis CCUG
2486 modulates DC function. In addition, L.GG was  the least effec-
ive probiotic strain in inducing IL-12 and IFN- by DCs, while LcS
as the most effective. These observations support previous stud-
es, which report that L.GG is not a very strong inducer of cytokine
roduction by monocyte-derived DCs (Latvala et al., 2008; Elmadfa
t al., 2010). It has been suggested that TLR2 (Plantinga et al.,
011) and nucleotide-binding oligomerization domain-2 (NOD2)
Zeuthen et al., 2008) are important in strain-speciﬁc induction
f pro-inﬂammatory cytokines by lactobacilli in DCs. On the other
and, LcS induces production of IL-12 by DCs, which is suggested
o be a key factor in the augmentation of natural killer cell activity
y LcS (Dong et al., 2010; Nanno et al., 2011).
In conclusion, this study demonstrates that four probiotic
trains promote maturation of, cytokine production by, and T-cell
riming capability of, human peripheral blood-enriched DCs. The
ffects were age-dependent, such that DCs from older subjects
ere more responsive to the effects of probiotics than those from
oung subjects. However, this is not the case for DC-induced T cellferences are denoted as P < 0.05 relative to no DC control for T cell with the same
me age group; T P < 0.05 relative to older T cell with the same treatment (post hoc
proliferation and, when older T cells were used in the MLR, pre-
treatment of young and older DCs with LPS or probiotics all failed
to prime T cells. This suggests that ageing increases the responsive-
ness of DCs to probiotics, but this cannot overcome the age-related
decline in the effective naïve T cell pool, and that probiotics alter
innate properties of DCs from older subjects, but not adaptive prop-
erties.
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